20413

524164

IOLCP

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

IOL CHEM AND PHARMA LTD Share Price Today

IOL CHEM AND PHARMA LTD is currently trading at ₹129.54, down by ₹3.3 from the previous close. The stock touched an intraday high of ₹136.50 and a low of ₹128.75 during the latest trading session. Over the past one year, IOL CHEM AND PHARMA LTD has delivered a return of 42.7%, while the stock has gained 30.99% in the last one month.

IOL CHEM AND PHARMA LTD performance

Today’s low Today’s high
₹ 128.75 ₹ 136.50
₹ 129.54
52 week low 52 week high
₹ 67.19 ₹ 139.99
₹ 129.54
Open Price ₹ 133.50
Prev. Close ₹ 132.84
Volume (Shares) 2078781.00
Total traded value ₹ 2692.85
Upper Circuit ₹ 159.40
Lower Circuit ₹ 106.28
info

Investment Returns

Over 1 Month 30.99% Over 3 Months 78.08% Over 6 Months 54.70% Over 1 Year 42.70%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

IOL CHEM AND PHARMA LTD fundamentals


  • Market cap (Cr) 3,802.40
  • P/E Ratio (TTM) 28.34
  • Beta 1.47
  • Book Value / share 61.26
  • Return on equity 6.12%
  • EPS (TTM) 4.98
  • Dividend yield 0.75%
  • Net profit/quarter (Cr) 53.18
info icon alternate text
  • Market cap (Cr) 3,799.70
  • P/E Ratio (TTM) 28.34
  • Beta 1.33
  • Book Value / share 61.26
  • Return on equity 6.12%
  • EPS (TTM) 4.98
  • Dividend yield 0.75%
  • Net profit/quarter (Cr) 53.18
info icon alternate text

IOL CHEM AND PHARMA LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 619.45
Operating Expense 550.36
Net Profit 53.18
Net Profit Margin (%) 8.58
Earnings Per Share (EPS) 1.81
EBITDA 94.30
Effective Tax Rate (%) 24.91
Particulars DEC 2025 (Values in Cr)
Revenue 580.39
Operating Expense 546.92
Net Profit 20.58
Net Profit Margin (%) 3.54
Earnings Per Share (EPS) 0.70
EBITDA 51.35
Effective Tax Rate (%) 25.29
Particulars SEP 2025 (Values in Cr)
Revenue 567.53
Operating Expense 533.89
Net Profit 30.00
Net Profit Margin (%) 5.28
Earnings Per Share (EPS) 1.02
EBITDA 63.98
Effective Tax Rate (%) 25.96
Particulars JUN 2025 (Values in Cr)
Revenue 551.69
Operating Expense 513.52
Net Profit 33.96
Net Profit Margin (%) 6.15
Earnings Per Share (EPS) 1.16
EBITDA 69.52
Effective Tax Rate (%) 25.42
Particulars MAR 2025 (Values in Cr)
Revenue 527.78
Operating Expense 487.40
Net Profit 31.62
Net Profit Margin (%) 5.99
Earnings Per Share (EPS) 5.38
EBITDA 67.46
Effective Tax Rate (%) 29.57
Particulars MAR 2026 (Values in Cr)
Revenue 2319.06
Operating Expense 2144.69
Net Profit 137.72
Net Profit Margin (%) 5.93
Earnings Per Share (EPS) 4.69
EBITDA 279.16
Effective Tax Rate (%) 25.33
Particulars MAR 2025 (Values in Cr)
Revenue 2079.21
Operating Expense 1963.72
Net Profit 101.00
Net Profit Margin (%) 4.85
Earnings Per Share (EPS) 17.20
EBITDA 224.57
Effective Tax Rate (%) 26.75
Particulars MAR 2024 (Values in Cr)
Revenue 2132.79
Operating Expense 1980.21
Net Profit 135.42
Net Profit Margin (%) 6.34
Earnings Per Share (EPS) 23.07
EBITDA 261.59
Effective Tax Rate (%) 25.85
Particulars MAR 2023 (Values in Cr)
Revenue 2217.11
Operating Expense 2053.19
Net Profit 139.98
Net Profit Margin (%) 6.31
Earnings Per Share (EPS) 23.84
EBITDA 252.09
Effective Tax Rate (%) 26.12
Particulars MAR 2022 (Values in Cr)
Revenue 2184.02
Operating Expense 1979.29
Net Profit 165.66
Net Profit Margin (%) 7.58
Earnings Per Share (EPS) 28.22
EBITDA 274.39
Effective Tax Rate (%) 25.65
Particulars MAR 2025 (Values in Cr)
Book Value / Share 57.49
ROE % 6.13
ROCE % 8.82
Total Debt to Total Equity 0.05
EBITDA Margin 10.81
Particulars MAR 2024 (Values in Cr)
Book Value / Share 274.49
ROE % 8.62
ROCE % 12.21
Total Debt to Total Equity 0.04
EBITDA Margin 12.22
Particulars MAR 2023 (Values in Cr)
Book Value / Share 256.81
ROE % 9.60
ROCE % 13.54
Total Debt to Total Equity 0.04
EBITDA Margin 11.33
Particulars MAR 2022 (Values in Cr)
Book Value / Share 237.15
ROE % 12.04
ROCE % 16.20
Total Debt to Total Equity 0.03
EBITDA Margin 12.66
Particulars MAR 2025 (Values in Cr)
Book Value / Share 57.48
ROE % 6.12
ROCE % 8.82
Total Debt to Total Equity 0.05
EBITDA Margin 10.80
Particulars MAR 2024 (Values in Cr)
Book Value / Share 274.46
ROE % 8.69
ROCE % 12.27
Total Debt to Total Equity 0.04
EBITDA Margin 12.27
Particulars MAR 2023 (Values in Cr)
Book Value / Share 256.61
ROE % 9.66
ROCE % 13.61
Total Debt to Total Equity 0.04
EBITDA Margin 11.37
Particulars MAR 2022 (Values in Cr)
Book Value / Share 236.80
ROE % 12.50
ROCE % 17.09
Total Debt to Total Equity 0.02
EBITDA Margin 12.56
Particulars MAR 2021 (Values in Cr)
Book Value / Share 214.69
ROE % 42.87
ROCE % 53.83
Total Debt to Total Equity 0.03
EBITDA Margin 31.32
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 208.15
Total Assets 2382.07
Total Liabilities 2382.07
Total Equity 1687.66
Share Outstanding 29
Price to Book Ratio 1.06
Return on Assets (%) 4.24
Return on Capital (%) 5.6
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 142.89
Total Assets 2244.40
Total Liabilities 2244.40
Total Equity 1611.51
Share Outstanding 5
Price to Book Ratio 1.32
Return on Assets (%) 5.98
Return on Capital (%) 8.18
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 21.83
Total Assets 2022.13
Total Liabilities 2022.13
Total Equity 1507.72
Share Outstanding 5
Price to Book Ratio 1.10
Return on Assets (%) 6.88
Return on Capital (%) 8.77
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 139.99
Total Assets 1962.30
Total Liabilities 1962.30
Total Equity 1392.28
Share Outstanding 5
Price to Book Ratio 1.49
Return on Assets (%) 8.54
Return on Capital (%) 11.68
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 207.94
Total Assets 2381.78
Total Liabilities 2381.78
Total Equity 1687.41
Share Outstanding 29
Price to Book Ratio 1.06
Return on Assets (%) 4.24
Return on Capital (%) 5.6
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 142.62
Total Assets 2243.97
Total Liabilities 2243.97
Total Equity 1611.33
Share Outstanding 5
Price to Book Ratio 1.32
Return on Assets (%) 6.03
Return on Capital (%) 8.24
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 20.90
Total Assets 2020.61
Total Liabilities 2020.61
Total Equity 1506.55
Share Outstanding 5
Price to Book Ratio 1.10
Return on Assets (%) 6.92
Return on Capital (%) 8.82
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 137.88
Total Assets 1960.29
Total Liabilities 1960.29
Total Equity 1390.27
Share Outstanding 5
Price to Book Ratio 1.49
Return on Assets (%) 8.45
Return on Capital (%) 11.56
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 364.74
Total Assets 1610.09
Total Liabilities 1610.09
Total Equity 1260.43
Share Outstanding 5
Price to Book Ratio 2.56
Return on Assets (%) 27.61
Return on Capital (%) 35.27
Particulars MAR 2025 (Values in Cr)
Net Income 137.96
Cash from Operations 196.94
Cash from Investing -154.18
Cash from Financing 46.04
Net change in Cash 70.48
Free Cash Flow 410.49
Particulars MAR 2024 (Values in Cr)
Net Income 181.65
Cash from Operations 331.80
Cash from Investing -190.98
Cash from Financing -92.50
Net change in Cash 6.30
Free Cash Flow 605.97
Particulars MAR 2023 (Values in Cr)
Net Income 188.65
Cash from Operations 169.37
Cash from Investing -120.00
Cash from Financing -4.11
Net change in Cash -1.84
Free Cash Flow 381.19
Particulars MAR 2022 (Values in Cr)
Net Income 224.85
Cash from Operations 155.63
Cash from Investing -120.52
Cash from Financing -1.64
Net change in Cash -29.11
Free Cash Flow 308.91
Particulars MAR 2025 (Values in Cr)
Net Income 137.89
Cash from Operations 197.00
Cash from Investing -154.23
Cash from Financing 46.04
Net change in Cash 70.49
Free Cash Flow 410.55
Particulars MAR 2024 (Values in Cr)
Net Income 182.64
Cash from Operations 332.48
Cash from Investing -191.39
Cash from Financing -92.50
Net change in Cash 6.57
Free Cash Flow 606.65
Particulars MAR 2023 (Values in Cr)
Net Income 189.49
Cash from Operations 170.24
Cash from Investing -119.19
Cash from Financing -4.11
Net change in Cash -0.16
Free Cash Flow 381.53
Particulars MAR 2022 (Values in Cr)
Net Income 222.84
Cash from Operations 153.62
Cash from Investing -120.62
Cash from Financing -1.64
Net change in Cash -31.22
Free Cash Flow 306.90
Particulars MAR 2021 (Values in Cr)
Net Income 571.39
Cash from Operations 522.03
Cash from Investing -317.25
Cash from Financing -58.28
Net change in Cash 4.25
Free Cash Flow 630.24
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.24 14.15 1.65 262.39 23.12 38.85
BLISS GVS PHARMA LTD 419.15 33.91 3.71 4434.14 118.35 462.70
CIPLA LTD 1388.25 29.46 3.25 112149.13 1165.55 1672.20
FERMENTA BIOTECH LTD. 341.00 15.04 2.46 1003.60 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.24 23.94 4.41 262.39 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 554.85 24.87 4.33 1604.11 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8383.40 109.49 24.01 20958.50 7630.00 10653.05
BLISS GVS PHARMA LTD 419.15 45.07 3.83 4434.14 118.35 462.70

IOL CHEM AND PHARMA LTD shareholding pattern

Holding
40.77%
57.47%
1.71%
0.02%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

IOL CHEM AND PHARMA LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
129.54 -2.48 redarrow
red-green-graph indicator
4 Bearish
12 Bullish
  • 5 Days 131.00
  • 26 Days 118.20
  • 10 Days 128.80
  • 50 Days 106.80
  • 12 Days 127.60
  • 100 Days 96.50
  • 20 Days 122.10
  • 200 Days 91.30
128.99 PIVOT
First Support 123.03 First Resistance 132.88 Second Support 119.14 Second Resistance 138.84 Third Support 113.18 Third Resistance 142.73
RSI 60.59 ADX 73.47 MACD 9.56 Williams % R -39.63 Commodity Channel Index (CCI) 56.45
Date 2026-06-08 Week 1085937.00 Same Day 722010.00 Month 1885923.00
1 Year 1.46 3 Year 1.26
Over 1 Month
30.99% down
Over 1 Year
42.70% down
Over 3 Months
78.08% down
Over 3 Years
12.04% down
Over 6 Months
54.70% down
Over 5 Years
-0.85% down

IOL CHEM AND PHARMA LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
17 Feb 2026 1.0 Interim 17 Feb 2026 Equity shares
18 Feb 2025 4.0 Interim 18 Feb 2025 Equity shares
16 Feb 2024 5.0 Interim 16 Feb 2024 Equity shares
17 Feb 2023 4.0 Interim 17 Feb 2023 Equity shares
15 Feb 2022 4.0 Interim 16 Feb 2022 Equity shares
08 Sep 2021 2.0 Final 12 Sep 2021 Equity shares
17 Nov 2020 4.0 Interim 18 Nov 2020 Equity shares
18 Mar 2020 3.0 Interim 1 19 Mar 2020 Equity shares
Ex-Date Old FV NEW FV Record Date
11 Mar 2025 10.0 2.0 11 Mar 2025
Dividend date Dividend amount Dividend type Record date Instrument type
17 Feb 2026 1.0 Interim 17 Feb 2026 Equity shares
18 Feb 2025 4.0 Interim 18 Feb 2025 Equity shares
16 Feb 2024 5.0 Interim 16 Feb 2024 Equity shares
17 Feb 2023 4.0 Interim 17 Feb 2023 Equity shares
15 Feb 2022 4.0 Interim 16 Feb 2022 Equity shares
08 Sep 2021 2.0 Final 12 Sep 2021 Equity shares
17 Nov 2020 4.0 Interim 18 Nov 2020 Equity shares
18 Mar 2020 3.0 Interim 1 19 Mar 2020 Equity shares
Ex-Date Old FV NEW FV Record Date
11 Mar 2025 10.0 2.0 11 Mar 2025

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of IOL Chemicals & Pharmaceuticals Ltd?

Answer Field

IOL Chemicals & Pharmaceuticals Ltd share price is for NSE ₹ 129.54 & for BSE ₹ 129.95 as on Jun 10 2026 03:30 PM.

What is the Market Cap of IOL Chemicals & Pharmaceuticals Ltd Share?

Answer Field

The market cap of IOL Chemicals & Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 10 2026 03:30 PM.

What is the 52 Week High and Low of IOL Chemicals & Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of IOL Chemicals & Pharmaceuticals Ltd for NSE is ₹ 139.99 and ₹ 67.19 and for BSE is ₹ 139.85 and ₹ 67.14.

What is 1 year return for IOL Chemicals & Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 49.35%.

What is the P/E Ratio of IOL Chemicals & Pharmaceuticals Ltd Share?

Answer Field

As on Jun 10 2026 03:30 PM the price-to-earnings (PE) ratio for IOL Chemicals & Pharmaceuticals Ltd share is 28.34.

What is the PB ratio of IOL Chemicals & Pharmaceuticals Ltd Share?

Answer Field

As on Jun 10 2026 03:30 PM, the price-to-book (PB) ratio for IOL Chemicals & Pharmaceuticals Ltd share is 61.26.

How to Buy IOL Chemicals & Pharmaceuticals Ltd Share?

Answer Field

You can trade in IOL Chemicals & Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy IOL Chemicals & Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy IOL Chemicals & Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “IOL Chemicals & Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|